Balkan Pharmaceuticals is a company founded in 2006 in the Republic of Moldova. In 2009, the company registered the first exports to Ukraine, and since 2010, it regularly wins the public tender for the purchase of medicines for the needs of clinics and hospitals in the country. The company has two factories for the production of medicines, one in Chisinau and another in Singera, in which more than 200 employees work. Balkan Pharmaceuticals has in its portfolio over 250 drugs in various forms and doses, among them are antitumor, hormonal drugs, drugs that act on the nervous, cardiovascular, digestive system, anti-inflammatory and analgesic preparations.
Joint Support, a product that supports performance athletes and beyond
Although they conquer the podiums, unfortunately, athletes are no exception when talking about joint ailments. Contrary to myths, performance sports and especially martial arts are a risk factor for damage to articular cartilage. In order to protect the joints, Balkan Pharmaceuticals comes with an innovative and ingenious solution: Joint Support, a perfect formula for both performance athletes and those who practice sports as amateurs.
Joint Support is the result of five years of intensive research and two years of clinical trials. This product has a unique and revolutionary composition with 12 standardized ingredients and active substances. Among them are Collagen Type 2 (UC-2), hydrolyzed bovine collagen type 1 and 3, hyaluronic acid, glucosamine, chondroitin sulfate, MSM (methylsulfonylmethane), turmeric and Boswellia serrata.
This product, obtained after years of research, is intended to cushion movements and increase mobility by lubricating joints, which is due to collagen and hyaluronic acid; to facilitate the reconstruction of destroyed cartilage by means of chondroitin and glucosamine and to decrease the symptoms of joint inflammation with the help of turmeric and Boswellia.
All this is possible thanks to the highest quality ingredients, taken from top leaders such as Lonza or Rousselot. The exclusivity of this product is also due to the fact that it contains three basic ingredients, which can be purchased on the market in three separate products. In other words, Joint Support is a 3 in 1 product.
Interestingly, this product can be used not only for treatment, but also for prophylactic purposes. Since with age, the prevalence of joint degeneration and a decrease in the density of bone tissue in osteoporosis, increases, Joint Support can be used as a protective shield against pathological joint degeneration. Also, this product can be used by young people who practice performance sports, to protect the joints from the problems to which they are exposed due to intensive training.
What happens when the joints are affected. Why we should worry
Rheumatic diseases have become a prevalent cause of declining quality of life for an increasing number of people. In the U.S., about 1 in 4 adults (23.7%) or about 58.5 million people have been diagnosed with arthritis. Arthritis mainly affects women, patients with comorbidities and sedentary people. Most importantly, arthritis increases in prevalence with age. The number of people suffering from these rheumatic diseases is expected to increase considerably in the near future. Thus, by the year 2040, about 78.4 million Americans will suffer from one form or another of arthritis.
No less important, osteoporosis, an emerging disease, which primary – affects the bone tissue, and secondary – affects the joints, affects an increasing number of people. It is estimated that there are 200 million people who suffer from osteoporosis. Also, 1 in 3 women and 1 in 5 men will experience at least one pathological fracture during their lifetime. Most of them, in the absence of proper treatment, are also likely to suffer from joint damage.
Regardless of how our joints are affected, the consequences are often the same. Whether we are talking about an autoaggression on the part of the immune system with activation of T lymphocytes from rheumatoid arthritis, an immune autoaggression caused by a recent infection with pathogenic germs (Campylobacter, E. Coli, Clostridium, etc.) from reactive arthritis, a progressive degradation of cartilage from osteoarthritis, or a necrosis of cartilage from osteochondrosis; all will result, in the first instance, with cartilage damage, and then with bone or periososal damage, if the diseases progress.
Joint Support, produced by Balkan Pharmaceuticals, contains two types of collagen but also other substances mentioned above. Therefore, the clinical effect of the use of the product is clearly superior, compared to single-component products. There is a lot of indisputable evidence about the benefit of collagen for the health of articular cartilage. In a study conducted in 2017 by the International Society for Osteo-arthritis research (C. M. Bagi and coauthor), it has been shown that the daily use of the clinical dose of Collagen Type 2, applied immediately after a cartilage damage, facilitated the restoration of the mechanical function of the joint and prevented its excessive degradation.